Iopamiro

Iopamiro® is an x-ray contrast medium of the new generation of non ionic compounds, and discovered by Bracco in 1981, which are watersoluble because the molecular structure incorporates hydrophilic groups. This new class of contrast media (Non-Ionics) differs significantly from earlier compounds (Ionics), all of which are soluble only when the radiopaque molecule is ionized by forming a salt with sodium and / or meglumine.

While Ionics are remarkably well tolerated, their aqueous solutions show an inherently high osmolality and this is responsible for a number of side effects that may occur after administration. The discovery of non ionic contrast agents has afforded, along with a sizable reduction of general toxicity, a considerable improvement in local and tissue tolerability, even for the more delicate structures of the human body such as vascular endothelia and the central nervous system

Iopamiro is the first water soluble non ionic discovered in the world, and safe (380 million doses sold worldwide), extensively documented (over 2000 published papers), and approved in wide range of indications including Pediatric populations. 

Iopamiro is a contrast agent for diagnosis of radiological procedures in Radiology, CT, Urography, HSG, DSA and interventional Cath Lab procedures in cardiac angiography, PTCA, etc.

• Iopamiro contains Iopamidol
• Available in 300mg and 370mg iodine concentration in 50ml & 100ml packaging.
• Iopamidol is US FDA Approved.